why choose us

First received: July 27, 2022

Clinical Trial: Efficacy of Dexamethasone to Improve Clinical Outcomes in Coronary Artery Bypass Patients

Study Status: Completed

Recruit Status: Completed

Condition: Coronary Artery Disease
Inflammatory Response

Study Type: Interventional


Official Title: Efficacy of Dexamethasone to Reduce Inflammatory Response and Improve Clinical Outcome in Coronary Artery Bypass Patients: A Multi Arm, Double Blind, Single Center, Randomized Controlled Trial

Brief Summary: This is a single-center, double-blind, randomized controlled clinical trial comparing four groups: placebo conventional coronary artery bypass graft (CCABG) group, dexamethasone CCABG group, placebo off-pump coronary artery bypass (OPCAB) group, and dexamethasone OPCAB group. The primary outcomes of this study is comprised of presence of arrhythmia, major adverse cardiac events (MACE), myocardial infarction, stroke, renal failure, respiratory failure, inflammation, and death. These primary outcomes were assessed…

Read more